ReviewThe efficacy of antifolate antimalarial combinations in Africa: a predictive model based on pharmacodynamic and pharmacokinetic analyses
References (54)
Antagonism of sulfadoxine and pyrimethamine antimalarial activity in vitro by p-aminobenzoic acid, p-aminobenzoylglutamic acid and folic acid
Mol. Biochem. Parasitol.
(1985)- et al.
A simple generalised equation for the analysis of multiple inhibitions of Michaelis—Menten kinetic systems
J. Biol. Chem.
(1977) - et al.
Treatment of malaria: some considerations and limitations of the current methods of assessment
Trans. R. Soc. Trop. Med. Hyg.
(1989) Drug resistant malaria
Endeavour
(1984)- et al.
Treatment of Plasmodium falciparum malaria with pyrimethaminesulfadoxine: selective pressure for resistance is a function of long elimination half life
Trans. R. Soc. Trop. Med. Hyg.
(1993) Point mutations and pyrimethamine resistance in Plasmodium falciparum
Parasitol. Today
(1989)Point mutations in the dihydrofolate reductase-thymidylate synthase gene as the molecular basis for pyrimethamine resistance in Plasmodium falciparum
Mol. Biochem. Parasitol.
(1989)- et al.
Comparison of in vitro pyrimethamine assays and in vivo response to sulfadoxine-pyrimethamine in Plasmodium falciparum from Papua New Guinea
Trans. R. Soc. Trop. Med. Hyg.
(1982) Response of Plasmodium falciparum to dihydrofolate reductase inhibitors in Malindi, Kenya
Trans. R. Soc. Trop. Med. Hyg.
(1986)Susceptibility of Plasmodium falciparum to pyrimethamine and sulfadoxine/pyrimethamine in Kisumu, Kenya
Lancet
(1982)
The changing response of Plasmodium falciparum to antimalarial drugs in East Africa
Trans. R. Soc. Trop. Med. Hyg.
(1988)
Chlorproguanil-dapsone for uncomplicated falciparum malaria in young children: pharmacokinetics and therapeutic range
Trans. R. Soc. Trop. Med. Hyg.
(1997)
Resistance to pyrimethamine-sulfadoxine in Plasmodium falciparum in 12 villages in North East Tanzania and a test of chlorproguanil-dapsone
Acta Trop.
(1997)
Polymorphism of the alleles of the merozoite surface antigens MSA1 and MSA2 in Plasmodium falciparum wild isolates from Colombia
Biochem. Parasitol.
(1991)
Clonal diversity in a single isolate of the malaria parasite Plasmodium falciparum
Trans. R. Soc. Trop. Med. Hyg.
(1984)
Chloroquine treatment of falciparum malaria in an area of Kenya of intermediate chloroquine resistance
Trans. R. Soc. Trop. Med. Hyg.
(1988)
Resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine (Fansidar) in a refugee camp in Thailand
Lancet
(1981)
(1970)
Chemotherapy of malaria and resistance to antimalarials
Tech. Rep. Series
(1973)
Folate metabolism in malaria
Bull. WHO
(1977)
Biochemistry of Plasmodium (malarial parasites)
Microbiol. Rev.
(1979)
De novo and salvage biosynthesis of pteroylpentaglutamates in the human malaria parasite Plasmodium falciparum
Mol. Biochem. Parasitol.
(1989)
Synergistic antimalarial activity of pyrimethamine and sulfadoxine against Plasmodium falciparum in vitro
Am. J. Trop. Med. Hyg.
(1984)
In vitro activities of and mechanisms of resistance to antifolate antimalarial drugs
Antimicrob. Agents Chemother.
(1985)
Measurement of the potencies of drug mixtures
Biometrics
(1969)
A method for testing synergy with any number of agents
J. Infect. Dis.
(1978)
Stage-specific sensitivity of Plasmodium falciparum to antifolates
Z. Parasitenkd.
(1986)
Cited by (137)
Mathematical Modelling to Guide Drug Development for Malaria Elimination
2017, Trends in ParasitologyMitigating the threat of artemisinin resistance in Africa: Improvement of drug-resistance surveillance and response systems
2012, The Lancet Infectious DiseasesInference and dynamic simulation of malaria using a simple climate-driven entomological model of malaria transmission
2022, PLoS Computational Biology
Copyright © 1997 Published by Elsevier Ltd.